Search research articles
Contact Us
Filters
Showing results (181-190 of 213) with videos related to
Page
of 22
Sort By:
JAMA Dermatology
|
May 2, 2019
Association of Time From Primary Diagnosis to First Distant Relapse of Metastatic Melanoma With Progression of Disease and Survival
Anaïs Vallet, Bastien Oriano, Laurent Mortier, et al.
Journal of the American Academy of Dermatology
|
November 29, 2005
Defining early mycosis fungoides
Nicola Pimpinelli, Elise A Olsen, Marco Santucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2016
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
Alexander Martens, Kilian Wistuba-Hamprecht, Marnix Geukes Foppen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2013
Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma
Antoni Ribas, Richard Kefford, Margaret A Marshall, et al.
Blood
|
August 16, 2011
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma
Werner Kempf, Katrin Pfaltz, Maarten H Vermeer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 12, 2023
First-Line, Fixed-Duration Nivolumab Plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401
Reinhard Dummer, Pippa Corrie, Ralf Gutzmer, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 7, 2024
Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors
Elise Jirovec, Dafne C A Quixabeira, James H A Clubb, et al.
Current Oncology (Toronto, Ont.)
|
December 22, 2022
Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France
Marguerite Kandel, Aurélie Bardet, Stéphane Dalle, et al.
Dermatology Practical & Conceptual
|
May 22, 2025
Management of Local Skin Reactions Caused by 5-FU 4% Cream for the Treatment of Actinic Keratosis: A Delphi Consensus
Gabriella Brancaccio, Giulia Briatico, Zoe Apalla, et al.
The New England Journal of Medicine
|
June 6, 2012
Improved survival with MEK inhibition in BRAF-mutated melanoma
Keith T Flaherty, Caroline Robert, Peter Hersey, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 213) with videos related to
Sort By:
Page
of 22
JAMA Dermatology
|
May 2, 2019
Association of Time From Primary Diagnosis to First Distant Relapse of Metastatic Melanoma With Progression of Disease and Survival
Anaïs Vallet, Bastien Oriano, Laurent Mortier, et al.
Journal of the American Academy of Dermatology
|
November 29, 2005
Defining early mycosis fungoides
Nicola Pimpinelli, Elise A Olsen, Marco Santucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2016
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
Alexander Martens, Kilian Wistuba-Hamprecht, Marnix Geukes Foppen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2013
Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma
Antoni Ribas, Richard Kefford, Margaret A Marshall, et al.
Blood
|
August 16, 2011
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma
Werner Kempf, Katrin Pfaltz, Maarten H Vermeer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 12, 2023
First-Line, Fixed-Duration Nivolumab Plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401
Reinhard Dummer, Pippa Corrie, Ralf Gutzmer, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 7, 2024
Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors
Elise Jirovec, Dafne C A Quixabeira, James H A Clubb, et al.
Current Oncology (Toronto, Ont.)
|
December 22, 2022
Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France
Marguerite Kandel, Aurélie Bardet, Stéphane Dalle, et al.
Dermatology Practical & Conceptual
|
May 22, 2025
Management of Local Skin Reactions Caused by 5-FU 4% Cream for the Treatment of Actinic Keratosis: A Delphi Consensus
Gabriella Brancaccio, Giulia Briatico, Zoe Apalla, et al.
The New England Journal of Medicine
|
June 6, 2012
Improved survival with MEK inhibition in BRAF-mutated melanoma
Keith T Flaherty, Caroline Robert, Peter Hersey, et al.
Page
of 22